 |
  |
|
Management
Team
david
m. geliebter
sven m. jacobson
janelle r. anderson
Scientific
Advisory Board Members
critical
diagnostics advisory board members
james v. snider,
Ph.D., president of critical diagnostics
james l. januzzi,
md
robert l. jesse,
md, Ph.D.
richard lee, md
alan stewart maisel,
md
david a. morrow,
md, mph
william franklin
peacock iv, md, facep
alan wu, Ph.D., D.A.B.C.C.
donna j. edmonds
cure
therapeutics' advisory board members
jose r. berrezueta, md,
Ph.D.
ronald m. burch, md,
PH.D.
bruce m gans, md
frank kochinke, Ph.D.
george a. c. murrell,
md, Ph.D.
barry p. simmons, md
lee s. simon, md
robert e. baldini, mba
(special advisor to the board)
susan l. michlovitz,
pt, Ph.D., cht (special advisor to the board)
remedy
pharmaceuticals' advisory board members
moses
v. chao, Ph.D.
gregory j. del
zoppo, md william
dalton dietrich, III, Ph.D.
ulrich dirnagl, md
edward d. hall, Ph.D.
j. marc simard, md,
Ph.D.
david g. sherman, md
chelsea s. kidwell,
md (special advisor to the board)
eugene d. means, md
(chief medical officer)
.
|
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
| |
 |
janelle r. anderson, Ph.D., general manager
Janelle oversees Carrot Capital Healthcare Venture’s
portfolio companies. She has a wide-ranging background in
both science and business. Before joining Carrot Capital Healthcare
Ventures, Janelle spent two years as a Consultant for The
Boston Consulting Group, working with many of the firm’s
leading healthcare clients. Prior to that, Janelle spent four
years as a Research Assistant at Harvard University, While
at Harvard, she was the inventor on three patents and author
of 11 publications. Janelle earned a B.Sc in Bio-organic Chemistry
from McGill University in 1995, an A.M. in Chemistry and Chemical
Biology from Harvard University (1998), and was graduated
from Harvard University in 2001 with a Ph.D. in Physical Chemistry.
return
to beginning >
|
 |
|
| |
 |
 |
 |
|
|
|